U.S. Colorectal Cancer Screening Market АНАЛИЗ РАЗМЕРОВ И ДОЛЕЙ - ТЕНДЕНЦИИ РОСТА И ПРОГНОЗЫ (2024 - 2031)
U.S. Colorectal Cancer Screening Market is Segmented By Test Type (Fecal Immunochemical Test (FIT), Guaiac-based Fecal Occult Blood Test, Stool DNA Test, and Others), By Imaging Type (Sigmoidoscopy, Colonoscopy, Virtual Colonoscopy, and Others), By End User (Hospitals, Diagnostic Laboratories, Academic and Research Institutes, and Others). The report offers the value (in USD billion) for the above-mentioned segments.
Competitive overview of U.S. Colorectal Cancer Screening Market
Основные игроки, работающие на рынке скрининга колоректального рака в США, включают Polymedco Inc., Eiken Chemical Co. Ltd., Sysmex Corporation, Quidel Corporation, Novigenix SA, Hemosure Inc., Exact Sciences Corp., Epigenomics Inc., Olympus Corporation, Clinical Genomics Technologies Pty Ltd., Abbott, F. Hoffmann-La Roche Ltd, Siemens Healthineers, Koninklijke Philips N.V., Thermo Fisher Scientific Inc., Illumina, Inc., Myriad Genetics Inc., QIAGEN, Merck KGaA
U.S. Colorectal Cancer Screening Market Leaders
- Polymedco Inc.
- Eiken Chemical Co. Ltd.
- Sysmex Corporation
- Корпорация Quidel
- Novigenix SA
U.S. Colorectal Cancer Screening Market - Competitive Rivalry, 2023
U.S. Colorectal Cancer Screening Market
(Dominated by major players)
(Highly competitive with lots of players.)